×

GGrowth Opportunities

Growth Prospects for the Global Consumer Wearables Sector

Wearable devices have often been dismissed by healthcare professionals as a consumer tool with 'fancy' features. Take a look at how healthcare delivery is changing and its impact on the wearables space, the key players, innovative business models, etc., that will transform its future.

Read more Request Info
New Investments Accelerate the Growth of the UK MedTech Sector

This sector in the UK is experiencing tremendous shifts. This research analyzes the landscape based on the developments, drivers and restraints, revenue and forecast assessment. Get insight into the emerging growth opportunities and growth environment portrayed in this analysis.

Read more Request Info
Public-Private Partnerships Transforming the KSA and UAE's Telehealth Industry

The telehealth industry covered in this research includes virtual visits, mHealth and remote patient monitoring (RPM). What is the forecast for the KSA and UAE telehealth segment until 2025? What are the profitable growth opportunities available? What are the challenges involved? Find out in this research.

Read more Request Info

CCxO Insights

FMCG 2025: 5 Strategic Pillars to Build Your Growth Pipeline/h4>

Nicolas Votano
Associate Partner

Fast-moving consumer goods (FMCG) companies are shaping their growth more than ever through constant innovation and the implementation of new technologies to serve their consumers better.

This traditional sector is at the heart of powerful industry convergences. Traditional value chains are impacted by transformative Mega Trends, disruptive technologies, and new business models that will reshape them faster than expected.

Five strategic pillars will support the FMCG industry in the next five years: digitization, personalization, sustainability, deglobalization and new business models.

Digitization is amongst the most disruptive trends for traditional FMCG players. From R&D to distribution, each building block of the value chain will be deeply impacted. AI, data analytics, IoT, robotics, machine learning, RPA and additive manufacturing are advanced technologies that will reshape FMCG research departments, factories, warehouses and stores while enhancing customer experience and engagement. These technologies will optimize internal processes and automate redundant and low value-added tasks. They will strengthen client intimacy by leveraging data to provide perfect custom solutions to billions of clients.

Schedule a consultation with an industry expert at no charge by contacting us at myfrost@frost.com. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.

FFrost Radar & Top Growth Insights

IVD

Frost Radar—Global Full Product Development CMO in the IVD Industry

Read more Request Info
Biosimilars

Access to New Therapy Areas Drives Growth in the Global Biosimilars Sector

Read more Request Info
Hemodynamic Monitoring

Growth in the Global Hemodynamic Monitoring Systems Industry

Read more Request Info
Gene Therapy Manufacturing

Growth Prospects in Contract Cell and Gene Therapy Manufacturing

Read more Request Info
Mental Health Care

Innovations Driving Growth in the Mental Health Care Sector

Read more Request Info
US & EU-5 Ventilator

Low-cost Devices with Simple Designs Growing in Response to COVID-19

Read more Request Info
POC Testing

Growth of the Global Infectious Disease Point-of-care Testing Sector

Read more Request Info
Computer-Assisted Coding

Growth of Computer-Assisted Coding Sector in Select EU Nations

Read more Request Info

Upcoming Research

What is the current and predicted impact of COVID-19 on the growth of virtual critical care solutions in the United States and EU-5 countries? Which platforms are expected to see faster adoption? How will the new competitive dynamics impact the ecosystem in the next five years?
Request Info

What are the recent developments within the clinical chemistry and immunoassay industry? What major commercial activities are shaping the IVD landscape? What are the high-potential short- and long-term opportunities to achieve growth?
Request Info

Why are the strategic imperative 8â„¢ impacting the growth of immuno-oncology (I-O) therapies? What are the characteristics of I-O therapies? How is the clinical trials snapshot for I-O therapies shaping up? What are the key growth opportunities in this space?
Request Info

What will be the revenue potential of the US and EU LIMS market from 2020 to 2026? What are the adoption trends and market growth curves of various products in the LIMS industry? What are the major growth opportunities in this industry?
Request Info

Press Releases

Global Biosimilars Market Poised to Grow at Chart-topping Levels with a CAGR of 17.3%, Reaching $79.2 Billion by 2026

Frost & Sullivan’s recent analysis, Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026, finds that the cost-benefit for end-users (patients) and ease of partnering with specialty contract development and manufacturing organizations (CDMOs) are driving the global biosimilars market. The third wave of biosimilars, with patent expiries from 2020 onward, is expected to hit the global market, covering complex biologic molecules like certain high-value mAbs and targeted therapies. The global biosimilars market is set to grow from $30.4 billion in 2020 to $79.2 billion by 2026 at a CAGR of 17.3%.

Read more

VeeMed Acclaimed by Frost & Sullivan for Enabling Operational Excellence with its Turnkey Telemedicine Solution

Based on its recent analysis of the North American telehealth market, Frost & Sullivan recognizes VeeMed, Inc. with the 2020 North American Entrepreneurial Company of the Year Award. Leveraging intelligent technologies, the company provides an integrated patient-side solution that positions telephysicians to diagnose, treat, and monitor acute care patients. The company partners with well-established healthcare providers and technology companies to address market gaps and disrupt the status quo by delivering customized hardware and device-agnostic software.

Read more

Frost & Sullivan Reveals Top Eight Predictions that Will Define Healthcare in 2021

The year 2020 has been game-changing. The pandemic and other geopolitical events left many businesses in an unprecedented state of uncertainty. Healthcare companies across the care continuum were faced with new challenges, and their extent and longevity are still unknown. Healthcare delivery has transformed, and the concept of “anytime anywhere care” will go mainstream. Vendors will need to redefine their visions and realign their strategies to ensure they are ready for 2021 and beyond.

Read more

What's New?

Growth Opportunity Briefings
  • Follow us  

Subscribe to the Health & Lifesciences Newsletter

Featured

Upcoming Events You Won't Want to Miss

Frost & Sullivan Institute

Click here to read moree